Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 1.90 Delayed Data As of 4:01pm ET |  0.00 / 0.00%Today’s Change | 1.67 Today|||52-Week Range 5.06 | -43.79% Year-to-Date |
Institutional investors purchased a net $14.8 million shares of CBAY during the quarter ended June 2019, and now own 72.44% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Other institutional | 56.66% |
| Mutual fund holders | 15.78% |
| Individual stakeholders | 12.86% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 3/31/2022 | RENAISSANCE TECHNOLOGIES LLC Bought 243.9 Thousand shares of Cymabay Therapeutics Inc |
| 3/31/2022 | GEODE CAPITAL MANAGEMENT LLC Bought 165.7 Thousand shares of Cymabay Therapeutics Inc |
| 3/31/2022 | AFFINITY ASSET ADVISORS LLC Bought 150.0 Thousand shares of Cymabay Therapeutics Inc |
Top 10 Owners of Cymabay Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Avoro Capital Advisor LLC | 12.16% | 10,300,000 | 23,381,000 | 0 | 0.00% |
| TCG Crossover Management LLC | 6.97% | 5,905,400 | 13,405,258 | +5,905,400 | -- |
| Commodore Capital LP | 6.40% | 5,419,896 | 12,303,164 | +1,250,000 | +29.98% |
| BlackRock Fund Advisors | 5.88% | 4,977,241 | 11,298,337 | +116,394 | +2.39% |
| The Vanguard Group, Inc. | 4.47% | 3,782,300 | 8,585,821 | +57,802 | +1.55% |
| Baker Bros. Advisors LP | 2.56% | 2,170,464 | 4,926,953 | 0 | 0.00% |
| Millennium Management LLC | 2.44% | 2,070,787 | 4,700,686 | +112,134 | +5.73% |
| Nantahala Capital Management LLC | 2.24% | 1,893,997 | 4,299,373 | -106,145 | -5.31% |
| DAFNA Capital Management LLC | 2.11% | 1,787,569 | 4,057,782 | +1,263,283 | +240.95% |
| Altium Capital Management LP | 2.07% | 1,750,000 | 3,972,500 | +1,750,000 | -- |
Top 10 Mutual Funds Holding Cymabay Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index... | 2.83% | 2,398,201 | 5,443,916 | 0 | 0.00% |
| iShares Russell 2000 ETF | 1.74% | 1,473,094 | 3,343,923 | -3,036 | -0.21% |
| Vanguard Extended Market Index Fu... | 1.12% | 946,307 | 2,148,117 | 0 | 0.00% |
| iShares Russell 2000 Value ETF | 0.91% | 771,045 | 1,750,272 | -2,712 | -0.35% |
| JPMorgan Small Cap Value Fund | 0.86% | 729,700 | 1,656,419 | 0 | 0.00% |
| FCP Medical - BioHealth | 0.86% | 727,141 | 1,650,610 | 0 | 0.00% |
| iShares Biotechnology ETF | 0.74% | 629,247 | 1,428,391 | -984 | -0.16% |
| Fidelity Small Cap Index Fund | 0.56% | 473,898 | 1,075,748 | +22,230 | +4.92% |
| Fidelity Extended Market Index Fu... | 0.40% | 334,091 | 758,387 | 0 | 0.00% |
| Brighthouse Funds Trust I - JPMor... | 0.31% | 262,100 | 594,967 | +262,100 | -- |